N2-Trityl Olmesartan Acid CAS 752179-89-8 Puritas > 98.0% (HPLC) Olmesartan Medoxomil Factory medium
Ruifu Chemical Supple Olmesartan Medoxomil media cum High Quality:
4,5-Dimethyl-1,3-Dioxol-2-Unum (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-Unum (DMDO-Cl) CAS 80841-78-7
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylatus CAS 144689-93-0
Diethyl 2-propyl-1H-Imidazole-4,5-Dicarboxylatus CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Acid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Nomen chemicum | N2-Trityl Olmesartan Acid |
Synonyma | Trityl Olmesartan Acidum (N2);Olmesartan N2-Trityl Impurity;4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ]methyl]-1H-Imidazole-5-Carboxylic Acid;4-(2-Hydroxypropan-2-yl)-2-propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) yl)1H-Imidazole-5-Carboxylic Acid |
CAS Number | 752179-89-8 |
CATTUS Number | RF-PI1876 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C43H40N6O3 |
M. Pondus | 688.82 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White pulveris |
Puritas / Analysis Methodus | >98.0% (HPLC) |
Damnum in Siccatio | <1.00% |
Residere in Ignition | <0.50% |
una immunditia | <1.00% |
Totalis immunditias | <2.00% |
Metalla gravia (ut Pb) | <20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Olmesartan Medoxomil (CAS: 144689-63-4); |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
N2-Trityl Olmesartan Acidum (CAS: 752179-89-8) medium est in synthesi Olmesartanae Medoxomil (CAS: 144689-63-4) compositarum affinium.Olmesartan Medoxomil angiotensin II receptor adversarius est qui adhibitus est ad curationem pressionis sanguinis altae.Olmesartan Medoxomil prodigus Olmesartanae est, angiotensin II speciei 1 receptor (AT1) inhibitor, qui opiniones regulatorias negativas de renini secretione vetat, aldosteronis secretionem decrescentem et in resistentia periphericis vascularium decrescentem (vasodilationem).Compositum hoc ostendit antihypertensivum, cardioprotectivum, vasodilatorium et actiones anti-inflammatoriae.Olmesartan Medoxomil solum adhiberi potest vel in compositione cum aliis agentibus antihypertensivis.In studiis clinicis comparativo aegrotis cum hypertensione essentiali, Olmesartan sedentem colaphos diastolici sanguinis pressionem signanter magis redegit quam Losartan, Valdesartan et Ibesartan, cum reductiones in systole sanguinis pressionis similes omnibus curationibus essent.